Sinovac Biotech Ltd.
SVA · NASDAQ
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | -$116,836 | $16,918 | -$370,646 |
| Dep. & Amort. | – | $60,596 | $84,149 | $78,838 |
| Deferred Tax | – | $108,448 | -$32,124 | -$67,173 |
| Stock-Based Comp. | – | $0 | $0 | $0 |
| Change in WC | – | $277,901 | $5 | $639,628 |
| Other Non-Cash | – | -$184,100 | $39,429 | -$930,007 |
| Operating Cash Flow | – | $146,009 | -$39,991 | $151,773 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | -$52,746 | -$92,942 | -$149,995 |
| Net Acquisitions | – | $2 | $37 | $5 |
| Inv. Purchases | – | -$1,702,870 | -$6,652,902 | $3,422,714 |
| Inv. Sales/Matur. | – | $1,560,427 | $4,014,860 | -$5,562,904 |
| Other Inv. Act. | – | $0 | $0 | $0 |
| Investing Cash Flow | – | -$195,187 | -$2,730,947 | -$2,290,180 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | $0 | $0 | $0 |
| Stock Issued | – | $0 | $676 | $0 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | -$293,227 | $217,164 | -$253,100 |
| Financing Cash Flow | – | -$293,227 | $217,164 | -$253,100 |
| Forex Effect | – | $0 | -$85,843 | -$189,210 |
| Net Chg. in Cash | – | -$371,463 | -$2,639,617 | -$2,580,717 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $1,646,760 | $4,286,377 | $6,867,094 |
| End Cash | – | $1,275,297 | $1,646,760 | $4,286,377 |
| Free Cash Flow | – | $93,263 | -$132,933 | $1,778 |